FTC Clears Kirin’s Acquisition Of Kyowa Hakko
This article was originally published in PharmAsia News
Executive Summary
The U.S. Federal Trade Commission March 25 approved Japanese brewer Kirin Holdings' acquisition of pharmaceutical company Kyowa Hakko Kogyo Co. The FTC announced that it had reviewed the case and found no concerns regarding competition. Kirin Holding has been buying Kyowa's stock, and plans to increase its holdings to 50.1 percent by April 1. Kirin Pharmaceutical Co., the pharmaceutical business division of Kirin Holdings, is scheduled to merge with Kyowa Hakko on Oct. 1. (Click here for more-Japanese language